Market Tracker

09/19 6:35pm ET

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

5.30
Data as of Sep 19
 -0.29 / -5.19%
Today’s Change
2.57
Today|||52-Week Range
9.01
+1.73%
Year-to-Date
No recent news for TherapeuticsMD Inc.

Today’s Trading

Previous close5.59
Today’s open5.57
Day’s range5.09 - 5.57
Volume5,280,431
Average volume (3 months)2,114,234
Market cap$871.0M
Dividend yield--
Data as of 4:02pm ET, 09/19/2014

Growth & Valuation

Earnings growth (last year)+42.11%
Earnings growth (this year)-31.06%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+129.85%
P/E ratioNM
Price/Sales75.74
Price/Book14.82

Competitors

 Today’s
change
Today’s
% change
TBPHTheravance Biopharma...-0.22-0.83%
EBSEmergent BioSolution...-0.40-1.80%
EPZMEpizyme Inc-0.90-3.29%
SRPTSarepta Therapeutics...-0.75-3.33%
Data as of 4:14pm ET, 09/19/2014

Financials

Next reporting dateNovember 3, 2014
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$8.8M
Annual profit (last year)-$28.4M
Net profit margin-323.84%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President, Secretary &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts